Company name:

Enanta Pharmaceuticals Inc

  • IPO SHARE PRICE:
    $14.00
  • IPO DATE:
    March 21, 2013
  • TICKER:
    ENTA
  • MAIN STOCK EXCHANGE:
    NASDAQ
  • CURRENT HQ LOCATION:
    500 Arsenal Street Watertown Massachusetts 02472
  • FISCAL YEAR END:
    September 30
  • INCORPORATION JURISDICTION:
    DE
  • ORGANIZED AS THE FOLLOWING LEGAL TYPE:
    Corporation
  • Investor Relations Webpage:
    Coming soon!
  • TAX RATE:
    USA federal corporate nominal income tax rate is 21%

Short Description

Enanta Pharmaceuticals Inc

We are working hard and as soon as possible to provide company description soon. Feel free to reach out to request it sooner: improve@real-clear-investing.com

Statement of Cash Flow

(USD in thousand)
Selected Year:
30-Sep
2020
OPERATING ACTIVITIES
Cash received and spent on operating activites of business — buying materials, paying salaries, receiving payments from clients, etc
42.7% - Accounts receivable
30.1% - Stock-based compensation
16.3% - Deferred income taxes
5.6% - Depreciation and amortization
4.9% - Operating lease right-of-use assets
0.5% - (Accretion) amortization of (discount) premium on marketable securities
SOURCEs
42.7% 4.9% 5.6% 16.3% 30.1%
100 %
0%
USES
10.9% 5.4% 17.5% 5.5% 55.5%
55.5% - Net income (loss)
17.5% - Prepaid expenses and other assets
5.5% - Premium paid on marketable securities
5.4% - Operating lease liabilities
2.1% - Accrued expenses
1.4% - Other liabilities
1.4% - Accounts payable
0.2% - Change in fair value of warrant liability and Series 1 non-convertible preferred stock
0.1% - Other non-cash items
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Net income (loss)
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$71,956 $46,383 ($36,168) ($57,939) ($33,312)
Depreciation and amortization
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
2,518 3,258 3,644 3,611 3,484
Stock-based compensation
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
15,845 19,226 19,575 19,360 19,532
(Accretion) amortization of (discount) premium on marketable securities (Accretion) amortization of (discount) premium on marketable securities
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
(835) (4,336) 304 1,065 1,724
Non-cash interest expense
$45,679
$45,679
$45,679
-
-
-
-
- - - - -
Excess tax benefit related to stock-options compensation Excess tax benefit related to stock-options compensation
-
$45,679
$45,679
$45,679
$45,679
-
-
- - - - -
Income tax benefit from stock awards
-
-
-
-
-
$45,679
$45,679
- - - - -
Deferred income taxes
-
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
1,858 (3,138) 10,608 9,951 -
(Gain) loss on sale of property and equipment
$45,679
$45,679
$45,679
-
-
-
-
- - - - -
Gain or loss on sale of marketable securities
-
$45,679
$45,679
-
-
-
-
- - - - -
(Gain) loss on derivative
$45,679
-
-
-
-
-
-
- - - - -
Change in fair value of warrant liability
$45,679
-
-
-
-
-
-
- - - - -
Change in fair value of warrant liability and Series 1 non-convertible preferred stock Change in fair value of warrant liability and Series 1 non-convertible preferred stock
-
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
59 - (149) (149) -
Premium paid on marketable securities
-
-
-
-
-
$45,679
$45,679
(319) (1,491) (3,575) (3,612) (4,100)
Other non-cash items
-
-
-
$45,679
$45,679
$45,679
$45,679
(75) 25 (51) (51) -
Unbilled receivables
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
-
- - - - -
Accounts receivable
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
(56,591) 15,892 27,821 20,827 (33,004)
Operating lease right-of-use assets
-
-
-
-
-
-
-
- - 3,184 3,816 4,608
Prepaid expenses and other assets
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
(918) (10,845) (11,397) (13,850) (5,228)
Other assets
$45,679
$45,679
$45,679
-
-
$45,679
$45,679
(92) - - - -
Accounts payable
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
1,317 1,791 (883) (129) 2,300
Income tax payable
-
-
$45,679
$45,679
$45,679
$45,679
$45,679
(7,910) (1,388) - - -
Accrued expenses
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
1,843 5,750 (1,368) 2,123 (9,992)
Deferred revenue
$45,679
$45,679
$45,679
-
-
-
-
- - - - -
Operating lease liabilities
-
-
-
-
-
-
-
- - (3,535) (4,231) (5,156)
Other liabilities
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
564 291 (922) (959) (416)
Net cash provided by (used in) operating activities
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$29,220 $71,418 $7,088 ($20,165) ($59,560)
Selected Year:
30-Sep
2020
INVESTING ACTIVITIES
Cash spent on acquiring plant, equipment and other businesses, cash recei0 from sale of plant, equipment and subsidiaries as well cash parked temporarily in different securities - government bonds typically
100.0% - Maturities and sales of marketable securities
SOURCEs
100.0%
100 %
0%
USES
5.5% 94.1%
94.1% - Purchases of marketable securities
0.4% - (Purchase) sale of property and equipment
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
(Increase) decrease in restricted cash and deposits
$45,679
$45,679
$45,679
-
-
-
-
- - - - -
Purchases of marketable securities
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
(293,103) (549,312) (338,553) (325,766) (418,696)
Sale of marketable securities
$45,679
$45,679
$45,679
$45,679
$45,679
-
-
- - - - -
Maturities of marketable securities
$45,679
$45,679
$45,679
$45,679
$45,679
-
-
- - - - -
Maturities and sales of marketable securities
-
-
-
-
-
$45,679
$45,679
260,682 468,065 359,828 366,497 349,668
(Purchase) sale of property and equipment
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
(2,981) (5,417) (1,445) (1,145) (752)
Other investing activities
-
-
-
$45,679
$45,679
-
-
- - - - -
Net cash provided by (used in) investing activities
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
($35,402) ($86,664) $19,830 $39,586 ($69,780)
Selected Year:
30-Sep
2020
FINANCING ACTIVITIES
Items in this group are concerned with borrowing funds, repaying debt, issuing equity, buying back shares, etc.
100.0% - Proceeds from issuance of common stock upon exercise of stock options and warrants
SOURCEs
100.0%
100 %
0%
USES
85.7% 14.3%
14.3% - Payments for settlement of share-based awards
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Initial Public Offering (IPO) net
$45,679
-
$45,679
-
-
-
-
- - - - -
Proceeds from issuance of common stock upon exercise of stock options Proceeds from issuance of common stock upon exercise of stock options
$45,679
$45,679
$45,679
$45,679
$45,679
-
-
- - - 14,964 -
Proceeds from issuance of common stock upon exercise of stock options and warrants Proceeds from issuance of common stock upon exercise of stock options and warrants
-
-
-
-
-
$45,679
$45,679
6,244 6,848 10,481 10,481 -
Payments for settlement of share-based awards
-
-
-
-
-
$45,679
$45,679
(1,756) (4,188) (1,498) (892) (2,136)
Initial public offering costs
$45,679
$45,679
$45,679
-
-
-
-
- - - - -
Issuance of Convertible Notes
$45,679
-
-
-
-
-
-
- - - - -
Repayment of convertible notes
$45,679
-
-
-
-
-
-
- - - - -
Repayments of capital leases
-
-
-
$45,679
$45,679
$45,679
$45,679
(79) (86) - - -
Payments of withholding tax on equity-based compensation Payments of withholding tax on equity-based compensation
-
-
-
-
$45,679
-
-
- - - - -
Income tax benefit from exercise of stock options
-
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
- - - - -
Net cash provided by (used in) financing activities
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$4,409 $2,574 $8,983 $8,116 $1,196
Selected Year:
30-Sep
2020
NET CHANGE IN CASH
Grand Total for sum of cash flows coming from operations, investing and financing
$35,901,000
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Cash and equivalents - Beginning of period
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$66,283 $64,510 $51,838 $188,202 $350,956
(Decrease) increase in cash and cash equivalents
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
(1,773) (12,672) 35,901 27,537 (128,144)
Cash and equivalents - End of period
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$64,510 $51,838 $87,739 $203,015 $222,812